Immune checkpoint therapy-elicited sialylation of IgG antibodies impairs antitumorigenic type I interferon responses in hepatocellular carcinoma.
Wu RQ, Lao XM, Chen DP, Qin H, Mu M, Cao WJ, Deng J, Wan CC, Zhan WY, Wang JC, Xu L, Chen MS, Gao Q, Zheng L, Wei Y, Kuang DM.
Wu RQ, et al. Among authors: chen ms, chen dp.
Immunity. 2023 Jan 10;56(1):180-192.e11. doi: 10.1016/j.immuni.2022.11.014. Epub 2022 Dec 22.
Immunity. 2023.
PMID: 36563676